VANCOUVER, BC and SEATTLE, WA, August 18th, 2020 – Chinook Therapeutics, Inc., a privately held clinical-stage biotechnology company focused on the discovery, development and commercialization of precision medicines for kidney diseases,… Read More
SAN DIEGO, Aug. 18, 2020 /PRNewswire/ — DelMar Pharmaceuticals, Inc. (Nasdaq: DMPI) (“DelMar” or the “Company”) announced today that it has entered into definitive agreements with investors providing for the sale and… Read More
VANCOUVER, BC, Aug. 17, 2020 /PRNewswire/ — Bold Therapeutics, a clinical-stage biopharmaceutical company, recently generated additional data supporting rapid clinical development of BOLD-100 as a novel antiviral. In a series of experiments conducted by… Read More
SAN DIEGO, Aug. 17, 2020 /PRNewswire/ — DelMar Pharmaceuticals, Inc. (Nasdaq: DMPI) (“DelMar” or the “Company”) announced today that all proposals related to the proposed merger between DelMar and Adgero were… Read More
NL-201 IND submission anticipated during the fourth quarter of 2020 Recent financing raises $71.4M in net proceeds to enable broad NL-201 clinical plan and product pipeline development into 2023 Company to host Conference… Read More
